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The human gut microbiota supplies its host with essential nutrients, including B-vitamins.
Using the PubSEED platform, we systematically assessed the genomes of 256 common
human gut bacteria for the presence of biosynthesis pathways for eight B-vitamins:
biotin, cobalamin, folate, niacin, pantothenate, pyridoxine, riboflavin, and thiamin. On
the basis of the presence and absence of genome annotations, we predicted that each
of the eight vitamins was produced by 40–65% of the 256 human gut microbes. The
distribution of synthesis pathways was diverse; some genomes had all eight biosynthesis
pathways, whereas others contained no de novo synthesis pathways. We compared our
predictions to experimental data from 16 organisms and found 88% of our predictions to
be in agreement with published data. In addition, we identified several pairs of organisms
whose vitamin synthesis pathway pattern complemented those of other organisms. This
analysis suggests that human gut bacteria actively exchange B-vitamins among each
other, thereby enabling the survival of organisms that do not synthesize any of these
essential cofactors. This result indicates the co-evolution of the gut microbes in the
human gut environment. Our work presents the first comprehensive assessment of the
B-vitamin synthesis capabilities of the human gut microbiota. We propose that in addition
to diet, the gut microbiota is an important source of B-vitamins, and that changes in the
gut microbiota composition can severely affect our dietary B-vitamin requirements.
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Introduction
The human gut microbiota (HGM) supplies its host with several nutrients, including amino acids
(Metges, 2000) and certain B-vitamins (Hill, 1997; Rossi et al., 2011). B-vitamins are necessary
cofactors for numerous aspects of human metabolism, including fat and carbohydrate metabolism
and DNA synthesis. Human cells are not capable of producing B-vitamins in sufficient amounts;
thus, these cells must obtain such vitamins either from the human diet or the gut microbiota
(Rucker et al., 2007).
B-vitamins are found in many food products, but they are water-soluble and many of them are
temperature sensitive; thus, these vitamins can easily be removed or destroyed during the cook-
ing process. B-vitamin deficiency is common in humans and supplements of these vitamins are
often used because deficiencies in these vitamins can lead to several diseases, such as pellagra
(Rucker et al., 2007). Therefore, there is great interest in the B-vitamin production by the gut
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microbiota, particularly because this production is thought to
play a role in maintaining the vitamin homeostasis in colono-
cytes (Rucker et al., 2007). Because of the large number of gut
microbial species, most of which have not been cultured, experi-
mental validation of the HGM B-vitamin pathways is infeasible,
at least with the current technologies. Genome annotations pro-
vide a method for both systematic and large-scale predictions of
pathways for vitamin metabolism, enabling assessments of the
potential of each species for vitamin biosynthesis.
Genome annotations can be obtained using, among other
methods, a genomics-based approach implemented in the Pub-
SEED platform (Overbeek et al., 2005; Disz et al., 2010). Pub-
SEED is amultifunctional web platform, in which one can inspect
defined sets of gene functional roles (annotations) for multiple
genomes at once and assign annotations to protein encoding
genes (PEGs), which refer to open reading frames (ORFs). A
functional role can refer to any protein-encoding gene and rep-
resents the protein function. Communities of experts define sets
of functional roles, called subsystems. These subsystems usually
contain functional roles that together form a metabolic pathway
for a particular subset of metabolism, for example, the biosynthe-
sis of vitamin B1 (thiamin). The subsystem can then be annotated
over any number of genomes at once. In addition, the Pub-
SEED platform offers multiple methods for the manual curation,
discovery, and assignment of functional roles.
In this study, we used the PubSEED platform to ana-
lyze 256HGM organisms for their ability to synthesize eight
B-vitamins. The genomes were selected based on a published col-
lection of microorganisms commonly found in the human gut
(Qin et al., 2010). We used eight B-vitamin subsystems, which
correspond to the biosynthesis of the active form of each vita-
min from its known precursors, to predict the possible B-vitamin
producers in the human gut as well as the potential competi-
tors for resources from the vitamin pools in the gut. In addi-
tion, we compared our predictions to experimental data available
in the literature on the B-vitamin requirements of 16 human
gut microorganisms. This work presents a comprehensive assess-
ment of the B-vitamin synthesis capabilities of the human gut
microbiota.
Materials and Methods
The PubSEED platform (http://pubseed.theseed.org/) (Overbeek
et al., 2005, 2013; Disz et al., 2010) contains fully annotated sub-
systems for eight B-vitamins: biotin, cobalamin, folate, niacin,
pantothenate, pyridoxine, riboflavin, and thiamin (Table 1).
The subsystems were populated with 256 HGM genomes. The
genomes were selected based on a study by Qin et al. (2010),
which reported microorganisms commonly found in the human
gut. A further selection criterion was that the microbes appeared
in at least 50% of the participants in the aforementioned study
and that their genomes were present in PubSEED (Supple-
mentary Table 1). For comparison, the subsystems were also
populated with 257 non-HGM genomes that were isolated
from human body sites other than the intestine (Supplementary
Table 1). The non-HGM genomes were chosen in the following
way: (1) All genomes from the Human Microbiome Project
TABLE 1 | Subsystems analyzed for the studied B-vitamins.
Vitamin Subsystem name Subsystem curator
Biotin “Biotin biosynthesis” Dmitry Rodionov
Cobalamin “Coenzyme B12 biosynthesis” Dmitry Rodionov
Folate “Folate Biosynthesis” Valérie de Crécy-Lagard
Niacin “NAD and NADP cofactor
biosynthesis global”
Andrei Osterman
Pantothenate “Coenzyme A Biosynthesis” Andrei Osterman
Pyridoxine “Pyridoxin (Vitamin B6)
Biosynthesis”
Olga Zagnitko
Riboflavin “Riboflavin, FMN, and FAD
metabolism Extended”
Sveta Gerdes
Thiamin “Thiamin biosynthesis” Dmitry Rodionov
The subsystems can be accessed on the PubSEED Subsystems Editor website:
http://pubseed.theseed.org/
(HMP, http://www.hmpdacc.org/HMRGD/) (The Human
Microbiome Project Consortium, 2012a,b) isolated from a
human body site were selected; (2) HMP genomes with the body
site “Gastrointestinal tract” (i.e., isolated from intestine) were
excluded; (3) all genomes absent from PubSEED were excluded;
(4) only one genome per species was selected; (5) among the
multiple genomes for the same species, a genome with a minimal
number of contigs (i.e., definitive) was selected; (6) if more
than one genome with the minimal number of contigs existed,
the genome with the maximal CDS number was selected. The
non-HGM genomes were isolated from the following body
sites: oral (127 genomes), urogenital tract (68 genomes), airways
(28 genomes), skin (25 genomes), blood (7 genomes), liver
(1 genome), and heart (1 genome).
Preparing and Populating the Subsystems
We first inspected the existing B-vitamin metabolism subsystems
and determined whether the functional roles associated with the
metabolism of each vitamin were consistent with most of the
recent reports. To enable us to manually curate the functional
roles involved in the biosynthesis of each vitamin, we copied
the existing subsystems to new subsystems. We then compiled
a list of HGM genomes by selecting a genome in the “Spread-
sheet” tab and clicking “save genome selection.” Using “Edit List,”
we selected our genomes and saved the list. Within the spread-
sheet for each subsystem, we limited the display of genomes
to our genome list in the window “User Sets.” To simplify our
analysis, we compiled functional roles with the same metabolic
functions into subsets using the “Subsets” tab. Protein encoding
genes (PEGs), which encode functional roles belonging to a cer-
tain pathway, often cluster together on a chromosome. In the
tab “Color Spreadsheet,” we colored the genes by cluster to bet-
ter identify these co-occurring genes. Finally, for each B-vitamin
subsystem, we determined sets of essential functional roles that
should be present in a genome for the corresponding organism
to be considered a vitamin producer (Table 2). Missing essential
roles in HGM genomes were manually curated where possible as
described below. The 257 non-HGM genomes were subjected to
the same criteria as those for the 256 HGM genomes.
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Manual Curation
The PubSEED platform offers several methods for manual cura-
tion. The function “Find candidates” uses four steps to search for
a functional role in a target genome. First, it looks for the role in
the target genome’s existing gene annotations. Then, it searches
for matching proteins in the genome by performing a similar-
ity check with protein BLAST algorithm (Altschul et al., 1990),
where it compares the amino acid sequence of the gene from
another genome with the amino acid sequences of all PEGs in
the target genome. The third step searches for genes, which are
co-localized on the chromosome with other genes from the sub-
system in the target genome. Finally, a translated BLAST (tblastn)
is performed, in which a query protein sequence is compared
with the six-frame translation of the target genome. Another
way to search for functional roles in the PubSEED platform is to
examine genome annotation phylogenetic trees for sets of related
proteins. Such trees show similarities among the amino acid
sequences of proteins from different genome clusters together
with the annotated functional role of each PEG. Trees often reveal
mis-annotations of the target genes and also provide hints of
the level of conservation of the sequence. For every protein-
encoding gene in the PubSEED platform, it is possible to examine
the NCBI Conserved Domains Database (CDD) (Marchler-Bauer
et al., 2013). The database performs an RPS-BLAST algorithm
(a stand-alone tool in the NCBI toolkit distribution), presents the
resulting protein domain annotations on the query sequence, and
lists the resulting E-values. High-confidence matches between
the query sequence and conserved domains are listed as “spe-
cific hits.” Once a candidate gene was found in a genome, the
functional role of the PEG was changed manually on the condi-
tion that the existing annotation was not associated with another
subsystem, because changing the annotation of a PEG affects all
subsystems that list the current annotation can alter the results of
TABLE 2 | Combinations of essential functional roles for the biosynthesis
the B-vitamins.
Pathway Essential functional roles
Biotin BioW + BioFADB
BioC + BioFADB
Cobalamin CbiL + CobG + CbiGF + (CobF or CbiD) + CbiECA + CobNST+
CobAT + CbiPB + CobUS
(CbiKX or CysG) + CbiLGF + (CobF or CbiD) + CbiECA + CobAT
+ CbiPB + CobUS
Folate FolEBKP + pabAc + DHFS + DHFR + FPGS
Niacin ASPOX + QSYN + QAPRT + NaMNAT + NADS
Pantothenate KPHMT + KPRED + ASPDC + PBAL + PANK + PPCS +
PPCDC + DPCK
Pyridoxine dxs + gapA + PdxBFAJH
PdxTS
Riboflavin GTPCH2 + PyrDR + DHBPS + DMRLS + RSA + RK + FMNAT
Thiamin (ThiH or ThiO) + ThiGSF + ThiCDE
Thi4 + ThiCDE
When more than one biosynthetic pathway for one vitamin is possible, several com-
binations of the essential roles are listed. Each abbreviation corresponds to the single
functional role (Supplementary Table 2).
an existing subsystem without notifying its author. Either a new
functional role was assigned to the PEG, or in the case of multi-
ple domains or functions, the new annotation was appended to
the existing ones.
Calculation of Vitamin Produced by Gut Microbes
We calculated the minimal number of microbes needed to supply
a human host with the necessary B-vitamins using the following
assumptions: (i) The number of bacterial cells in the colonic space
is 1014 cells (Savage, 1977). (ii) The dry weight of a single bacterial
cell is 4.89 ∗ 10−13 gDW cell−1 (Loferer-Krößbacher et al., 1998).
(iii) Intracellular vitamins in bacteria become available to the host
upon cell lysis. (iv) 31.7% of bacterial cells in fecal matter has been
reported to consist of dead cells (Ben-Amor et al., 2005). The ratio
of dead cells in the colon could not be found, and we therefore use
the measured ratio of dead cells in the feces in our calculations.
(v)The intracellular concentration of vitamins was retrieved from
the literature (Table 3) but represents only the capacity of those
bacteria and not all gut bacteria in general. (vi) The volume of an
E. coli cell is 1.1µm3 (Kubitschek and Friske, 1986). (vii) The dry
weight of an E. coli cell is 4.89 ∗ 10−13 gDW (Loferer-Krößbacher
et al., 1998). (viii) E. coli grows anaerobically at 0.26 h−1 (Hasona
et al., 2004).
The ratio of the human daily reference intake of each vitamin
coming from bacteria could then be calculated in the following
manner:
% of DRI =
Intracellular concentration ∗Weight of
bacteria ∗ AM ∗ HGM ratio
DRI
∗ 100
where DRI is the recommended dietary reference intake in
mg/day, AM is the atomic mass of the vitamin [values from
ChEBI, (Hastings et al., 2013)], and HGM is the ratio of HGM
producers as predicted in this study.
TABLE 3 | Intracellular vitamin concentrations in selected gut microbes.
Vitamin Organism Reported
value
References
Biotin E. coli 40µM Cicmanec and Lichstein,
1978
Cobalamin Lactobacillus
reuteri CE
50µg/L Taranto et al., 2003
Flavin E. coli 4µM Wilson and Pardee,
1962
Folate derivatives Lactobacillus
casei
22µM Shane and Stokstad,
1976
Niacin E. coli 1.12 * 106
molecules in
a single cell
McLaren et al., 1973
Pantothenate E. coli <1µM Jackowski and Alix,
1990
Pyridoxine E. coli 1.5 * 10−10
mol h−1
mgDW−1
Dempsey, 1971
Thiamine Lactobacillus
fermenti
3µg/gDW Sompolinsky and
Neujahr, 1971
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Results
Pathway Descriptions, Prediction Criteria, and
Predictions
For each of the eight B-vitamins, we describe the known biosyn-
thesis pathways and for each pathway, we present the frequency
of the respective functional roles in the analyzed taxonomic
groups. Based on the functional roles present in the subsys-
tems, each HGM organism was predicted to be a producer or
non-producer of the eight B-vitamins (Supplementary Table 1).
Biotin (Vitamin B8)
Biotin can be synthesized de novo from two pimeloyl precursors,
malonyl-ACP and pimelate (Figure 1). There are five different
synthesis routes (Rodionov et al., 2002; Lin and Cronan, 2011)
but only three, via BioG, BioH, and BioW, could be identified in
the 256HGM genomes.
We examined the prevalence of the BioC route using the
BioG role in the 256HGM genomes. Almost all genomes
from the phylum Bacteroidetes (96%) were predicted to syn-
thesize biotin through this route. All analyzed genomes from
the phylum Fusobacteria were predicted to synthesize biotin
through the BioC route with BioG. A single Fusobacteria genome,
Fusobacterium sp. D11, was missing the essential role BioC, but it
was still predicted to be a producer because the genome contained
all other essential roles and all its related genomes contained
BioC. In the phylum Proteobacteria, 84% of the genomes were
predicted to synthesize biotin. Producers from the class Epsilon-
proteobacteria contained the BioG role, whereas the remain-
ing producers in the phylum, which were mostly from the
class Gammaproteobacteria, contained a BioH. Only a single
Gammaproteobacteria, Escherichia sp. 1_1_43, was a predicted
non-producer.
We then examined the second biosynthesis route, in which
BioW is used to convert salvaged pimelate to pimeloyl-CoA.
The BioFADB pathway is then used to convert pimeloyl-CoA to
biotin. This route was only observed in the Firmicutes phylum
in five genomes from the Clostridia class and in Bacillus subtilis
subsp. subtilis str. 168. During our analysis, we observed that all
Actinobacteria genomes lacked the essential biotin biosynthesis
roles. However, 19 of the 23 (83%) Actinobacteria genomes con-
tained a BioY biotin transporter, indicating a need for biotin.
The remaining four genomes, all from the family Coriobac-
teriaceae, contained no functional roles in the pathway at all,
but they did contain biotin-protein ligases, suggesting that they
require biotin.
FIGURE 1 | Biotin biosynthesis. The biotin biosynthesis subsystem
contains 9 functional roles (Supplementary Table 2) and 10
metabolites. Functional roles are represented by rectangles. The major
biosynthesis routes are colored green, alternative routes are blue,
salvage routes are red, and known transporters are yellow. Metabolites
are represented by circles, and yellow circles represent metabolites
that can be salvaged from the environment in some cases. Only the
core metabolites of the biosynthesis pathway are listed. Each bar
graph represents the percentage of organisms in each phylum that
contain the functional role.
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Taken together, these findings show that the majority of Bac-
teroidetes, Fusobacteria, and Proteobacteria genomes contain the
essential roles for biotin biosynthesis (Figure 1). The synthesis of
this vitamin is completely absent in Actinobacteria genomes and
is very rare in genomes of the Firmicutes phylum. In total, biotin
biosynthesis is present in 40% of the HGM genomes.
Cobalamin (Vitamin B12)
Cobalamin biosynthesis contains the longest pathway of eight
vitamins, where adenosylcobalamin is synthesized from precor-
rin 2 (Figure 2). The cobalamin can be synthesized either aer-
obically or anaerobically (blue and green pathways in Figure 2,
respectively).
No HGM microbe used the aerobic biosynthesis route,
whereas some non-HGM producers contained the aerobic
pathway specific roles CobG and CobNST. Only two Acti-
nobacteria of the Coriobacteriaceae family were predicted
cobalamin producers, Collinsella aerofaciens ATCC 25986 and
Gordonibacter pamelaeae 7-10-1-b. Only half of the genomes in
the Bacteroidetes phylum (26 of 51) were predicted to be a cobal-
amin producers being the lowest producer ratio observed for the
Bacteroidetes of all eight vitamins. No taxonomic patterns were
observed for the Bacteroidetes producers. Nearly half of the Fir-
micutes genomes (43%) were predicted to synthesize cobalamin.
All Lactobacillales were predicted to be non-producers, except
the six Lactobacillus reuteri strains that have been previously
known to have this pathway (Santos et al., 2008). Only a single
other Bacilli, Listeria monocytogenes str. 1/2a F6854, was a pre-
dicted producer of this vitamin. The remaining cobalamin pro-
ducers in the Firmicutes phylum belonged to the Clostridia class,
but no specific taxonomic pattern was observed. All 14 Fusobac-
teria were predicted to be cobalamin producers. The Proteobacte-
ria phylum contained only ten producers, three from Delta- and
seven from Gammaproteobacteria.
Taken together, we find that cobalamin biosynthesis is present
in 42% of the HGM genomes. The synthesis of cobalamin is
present in all Fusobacteria, but is rare in Actinobacteria and Pro-
teobacteria. Half of the Bacteroidetes genomes are missing the
FIGURE 2 | Cobalamin biosynthesis. The cobalamin biosynthesis
subsystem contains 17 functional roles (Supplementary Table 2) and 15
metabolites. Refer to Figure 1 for figure descriptions. Note that we show
only CbiD since none of the HGM genomes contained CobF. The “* or **”
text in the first green box on the top left corner of the figure refer to two
functional roles “*CbiKX” and “**CysG”. The corresponding bar charts for the
two functional roles are shown below the green box, just above the
“Abbr./Metabolites” table.
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biosynthesis pathway, making cobalamin the least produced of
the eight vitamins in the phylum.
Folate (Vitamin B9)
Folate biosynthesis includes the combination of two metabolic
branches (Figure 3). The first branch converts guanosine triphos-
phate (GTP) to 6-hydromethyl-7,8-dihydropterin and the sec-
ond branch converts chorismate to p-aminobenzoic acid (PABA).
Most living organisms contain more than one folate derivative.
However, because these folates are derived from dihydrofolate
(DHF) or tetrahydrofolate (THF), we considered the produc-
tion of either metabolite to be sufficient to assign folate producer
status to a genome.
From our data, we identified 109 predicted folate producers,
86% of which included all the functional roles of the pathway
or were only missing the FolQ role, which is commonly missing
in genome annotations (Gerdes et al., 2012). All producers were
required to have the pabAc role of the PABA synthesis branch
of the pathway. The two other roles, pabAa and pabAb, were
commonly missing from our genomes, and the assignment of the
roles frommanual inspection was not trivial. Therefore, the pres-
ence of pabAa or pabAb was not considered essential, although
these roles, along with pabAc, are needed for the synthesis of
PABA. A PABA auxotroph must acquire the metabolite from its
growth medium and was therefore not considered to be capable
of producing folates de novo. Only six (26%) Actinobacteria were
predicted producers: five from the order Bifidobacteriales and
one from the order Actinomycetales. Although most genomes
in this phylum had all the necessary functional roles for THF
production, they did not contain pabAc. All but four (92%) Bac-
teroidetes were predicted to synthesize folates; the four excep-
tions lacked pabAc. Only 18 Firmicutes had complete synthesis
pathways. Of the remaining 112 Firmicutes genomes, 49 con-
tained a full biosynthesis pathway but were missing the PABA
branch. The other genomes were predicted non-producers, but
contained roles for the conversion of dihydropteroate to THF,
suggesting that they rely on folate uptake. Three Fusobacteria
were predicted to be PABA auxotrophs, whereas the remain-
ing 11 (79%) genomes contained all the essential roles for folate
biosynthesis. The Proteobacteria phylum demonstrated more
variability and class-specific patterns, with 71% of the organ-
isms predicted as producers. The Betaproteobacteria included
three producers, whereas two genomes from this class were miss-
ing PABA biosynthesis. All Deltaproteobacteria were predicted
to be non-producers. The Gammaproteobacteria demonstrated
the highest conservation of the pathway; all functional roles were
present. Only two non-producers were observed in the class: Suc-
cinatimonas hippei YIT 12066 was missing the PABA branch,
and Escherichia sp. 1_1_43 was missing the PABA branch, FolE,
DHFS, and FPGS.
Taken together, these findings show that the folate biosyn-
thesis pathway is present in nearly all Bacteroidetes genomes as
FIGURE 3 | Folate biosynthesis. The folate biosynthesis subsystem contains 11 functional roles (Supplementary Table 2) and 14 metabolites. Refer to Figure 1 for
figure descriptions.
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well as in most Fusobacteria and Proteobacteria. Folate synthesis
is rare in the Actinobacteria and Firmicutes genomes, mostly
because of the absence of the PABA biosynthesis pathway. In
total, folate biosynthesis is complete in 43% of the 256 HGM
genomes tested.
Niacin (Vitamin B3)
Niacin is a group term for nicotinamide and nicotinic acid, and
both of these metabolites are precursors for nicotinamide ade-
nine dinucleotide (NAD). Nicotinamide and nicotinic acid can
either be salvaged from the environment or produced through
the recycling of NAD within the cell (Gossmann et al., 2012). In
this study, an organism was considered a niacin producer when
it contained the de novo synthesis pathway of NAD (Begley et al.,
2001) (Figure 4).
The first route uses the functional role NaMNAT to pro-
duce deamino-NAD, which in turn is converted to NAD by
NADS. NADS requires ammonia, or alternatively, NADS is cou-
pled to a glutaminase domain (GAT) that supplies ammonia (De
Ingeniis et al., 2012). In this study, the presence or absence of
the GAT domain did not affect our predictions. All predicted
producers among the 256 genomes contained both NaMNAT
and NADS. In the case of Firmicutes, the Bacilli class contained
only five producers and the Clostridia class included 44 predicted
niacin producers. Most Fusobacteria were predicted to synthesize
niacin, with only two predicted non-producers. Proteobacteria
contained 29 predicted niacin synthesizers, but no taxa-specific
patterns were observed.
Considering the prevalence of the first biosynthesis route in
the gut microbiota, we wondered how common the alternative
synthesis route was in these genomes. This route produces nicoti-
nate D-ribonucleotide from quinolinic acid through NMNS and
converts it to NAD using NMNAT. Only eight of the analyzed
genomes contained both of these functional roles, and all con-
tained the roles NaMNAT and NADS from the first route as
well. All eight genomes belonged to the Firmicutes phylum, seven
from the Clostridia class and one from Erysipelotrichia. Some
prokaryotic cells share the eukaryotic NAD biosynthesis path-
way from tryptophan (Kurnasov et al., 2003). However, we did
not observe any evidence of an active tryptophan pathway in our
list of HGM genomes. Because niacin is known to be salvaged
from the environment, we investigated the functional roles asso-
ciated with the uptake of three NAD precursors: nicotinamide,
nicotinic acid, and N-ribosylnicotinamide. We found that the
roles associated with the uptake of the nicotinamide and nico-
tinic acid (Figure 4) were only present in Actinobacteria, Fir-
micutes, and a single Proteobacteria. Two roles associated with
the conversion of salvaged niacin to nicotinate mononucleotide
FIGURE 4 | Niacin biosynthesis. The niacin biosynthesis subsystem contains 14 functional roles (Supplementary Table 2) and 10 metabolites. Refer to Figure 1 for
figure descriptions.
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(NAM and NAPRT) were present in all five phyla, but these roles
are involved in the recycling of NAD (Gossmann et al., 2012)
and therefore do not necessarily indicate the presence of niacin
salvage. The salvage of N-ribosylnicotinamide through PnuC,
RNK, and NMNAT was only present in four Firmicutes and 18
Proteobacteria.
Taken together, these findings show that niacin biosynthesis
is present in the majority of the HGM genomes. The phyla Acti-
nobacteria and Firmicutes contain lower ratios of de novo pro-
ducers than the other three, and in these phyla, we observed the
presence of the niacin salvage pathways, which are not present
in the Fusobacteria and Bacteroidetes genomes. A total of 63%
of all the investigated genomes contained the NAD biosynthesis
pathways.
Pantothenate (Vitamin B5)
Pantothenate is a precursor for coenzyme A (CoA) and it can
be synthesized de novo from 2-dihydropantoate and β-alanine
(Figure 5). Because CoA is the active form of pantothenate, we
considered the de novo pantothenate biosynthesis pathway to be
complete when a genome contained the functional roles needed
for CoA biosynthesis. Although this pathway is well defined, it
caused many uncertainties in our analysis. Many of the analyzed
genomes were missing the roles KPHMT or ASPDC. When a
genome was missing a single enzyme in the branched pathway,
the organisms were still predicted to be a pantothenate producer.
Some genomes were lacking the role PBAL, which is the final step
of pantothenate biosynthesis. Hence, the absence of PBAL always
resulted in a non-producer prediction.
According to our predictions, Fusobacteria, certain Acti-
nobacteria, and Firmicutes do not possess the ability to synthesize
pantothenate (Figure 5). These predictions were mostly based
on the absence of two or more of the functional roles KPHMT,
KPRED, ASPDC, and PBAL. All Bacteroidetes and 36 (95%) of
the Proteobacteria genomes were predicted to be CoA producers.
Only three Actinobacteria were predicted CoA producers: two
of the Actinomycetales order and one Coriobacteriales. None of
the Bifidobacteriales contained a full CoA biosynthesis pathway,
but all genomes in the order contained the pantothenate trans-
porter PANF. The four non-producing Coriobacteriales genomes
did not contain a PANF transporter. Firmicutes displayed cer-
tain class-level similarities, with 32% of the genomes contain-
ing the essential roles for CoA biosynthesis. Only seven Bacilli,
including three Bacillales and four Lactobacillales, contained all
CoA-biosynthesis roles. The Clostridia class demonstrated con-
siderable variability in the presence of roles, and no specific pat-
tern could be observed for the lower taxa. In the phylum Pro-
teobacteria, all organisms of the Betaproteobacteria class except
FIGURE 5 | Pantothenate biosynthesis. The pantothenate biosynthesis subsystem contains 10 functional roles (Supplementary Table 2) and 12 metabolites. Refer
to Figure 1 for figure descriptions.
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one contained all essential functional roles for CoA biosynthesis,
whereas none of the producers presented a PANF transporter.
All Delta- and Epsilonproteobacteria were predicted to be pro-
ducers. All Gammaproteobacteria contained all roles in the path-
way, except a single genome of the order Aeromonadales was
missing three out of the four necessary steps for pantothenate
biosynthesis.
Taken together, these findings demonstrate that the synthesis
of CoA from pantothenate is present in nearly all HGM genomes.
However, pantothenate biosynthesis is not present in Fusobacte-
ria and is only present in a few Actinobacteria and Firmicutes.
Nearly all Bacteroidetes and Proteobacteria contain a full biosyn-
thesis pathway for both pantothenate and CoA. CoA biosynthesis
is present in 51% of the HGM genomes.
Pyridoxine (Vitamin B7)
The coenzyme form of pyridoxine is pyridoxal 5′-phosphate and
is required for several enzymes in the cell, mainly those required
for the metabolism of amino acids (Dakshinamurti and Dak-
shinamurti, 2007). Pyridoxal 5’-phosphate can be synthesized de
novo via two different routes (Figure 6).
We first analyzed the shorter biosynthesis route, which uses
a single enzyme with two domains, represented by the func-
tional roles PdxS and PdxT. This route joins glyceraldehyde
3-phosphate and D-ribulose 5-phosphate to produce pyridoxal
5′-phosphate. Both roles must be present for an organism to
be a predicted producer. The 20 Actinobacteria and 33 Firmi-
cutes genomes that were predicted to be pyridoxine producers
contained the PdxTS roles. Only three Bacteroidetes producers
contained the PdxTS route: two from the Prevotellaceae fam-
ily and one Rikenellaceae, A. indistinctus YIT 12060, which also
contained the alternative biosynthesis route described below.
The three Fusobacteria producers contained PdxTS; four Pro-
teobacteria producers (i.e., the three Deltaproteobacteria and
a single Gammaproteobacteria, A. junii SH205) also contained
PdxTS.
We then examined the alternative synthesis route, which
requires seven functional roles for a complete pathway
made of two branches. One branch converts D-erythrose-4-
phosphate to 3-amino-2-oxopropyl phosphate in four steps.
The other branch converts D-glyceraldehyde-3-phosphate to
1-deoxy-D-xylulose-5-phosphate with the functional role dxs
FIGURE 6 | Pyridoxine biosynthesis. The pyridoxine biosynthesis subsystem contains 11 functional roles (Supplementary Table 2) and 16 metabolites. Refer to
Figure 1 for figure descriptions.
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(Figure 6). The two end-metabolites are joined by PdxJ and
converted to pyridoxal 5′-phosphate by PdxH. Both PdxJ and
PdxH were required for an organism to be a predicted pyri-
doxine synthesizer. Only genomes from the Bacteroidetes and
Proteobacteria phyla contained the roles PdxJ and PdxH in addi-
tion to the remaining essential functional roles of the pathway
(Table 2); therefore, Bacteroidetes and Proteobacteria were the
only phyla predicted to synthesize pyridoxine via this route.
All Gammaproteobacteria, with the exception of Escherichia sp.
1_1_43, contained a full PdxJH biosynthesis route. Only three
Bacteroidetes genomes—Bacteroides coprocola DSM 17136, Bac-
teroides coprophilus DSM 18228, and Bacteroides plebeius DSM
17135—were predicted to be non-producers. All three genomes
were missing PdxH but contained all other functional roles of the
pathway.
The results for the two routes showed that themajority of Acti-
nobacteria, Bacteroidetes, and Proteobacteria have the ability to
synthesize pyridoxal 5′-phosphate. Most Bacteroidetes and Pro-
teobacteria use the longer route, and all Actinobacteria contain
the shorter synthesis route. Only few Firmicutes and Fusobacteria
can synthesize pyridoxal 5′-phosphate, but those that do use the
shorter PdxTS route. Taken together, these findings reveal that
the de novo biosynthesis of pyridoxal 5′-phosphate is present in
50% of the tested HGM genomes. The majority of genomes from
all phyla, except for Fusobacteria, contained the role PdxK, which
is involved in the salvage of pyridoxal 5′-phosphate and its two
precursors.
Riboflavin (Vitamin B2)
Riboflavin can only be synthesized through one known pathway
fromGTP and D-ribulose-5-phosphate (Figure 7). The role PyrP
is commonly missing in our genomes and is commonly missing
in plants (Gerdes et al., 2012); thus, its absence did not affect
our predictions. For an organism to be considered a predicted
producer, its genome had to present all other functional roles to
produce the redox cofactors FMN and FAD.
All Bacteroidetes and Fusobacteria and 36 genomes (92%)
of Proteobacteria contained all essential functional roles for
riboflavin biosynthesis (Figure 7, Table 2). Half of the Firmi-
cutes were predicted to be riboflavin producers. This ratio is the
largest in Firmicutes producers among all of the vitamins in our
analysis. Although riboflavin biosynthesis was the most promi-
nent in Firmicutes, no taxa-specific patterns were found. Only
two genomes in the Actinobacteria phylum had all the essential
roles for riboflavin biosynthesis: Corynebacterium ammoniagenes
DSM 20306 and Bifidobacterium longum ATCC 15697. All Bac-
teroidetes were predicted producers. All but two genomes from
Proteobacteria were predicted to synthesize riboflavin.
FIGURE 7 | Riboflavin biosynthesis. The riboflavin biosynthesis subsystem contains 10 functional roles (Supplementary Table 2) and 11 metabolites. Refer to
Figure 1 for figure explanations.
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The riboflavin biosynthesis pathway was themost preserved of
the eight vitamins we examined, although it was absent inmost of
the Actinobacteria genomes and half of the Firmicutes genomes.
However, all non-producing organisms from the two phyla con-
tained the RibU riboflavin transporter role, indicating their need
for the riboflavin-derived cofactors FMN and FAD. RibU was
almost completely absent in the Bacteroidetes, Fusobacteria, and
Proteobacteria, whereas the de novo synthesis pathway was found
in nearly all genomes of the three phyla. The majority of all 256
genomes (65%) had the ability to produce riboflavin.
Thiamin (Vitamin B1)
The thiamin biosynthesis pathway consists of two branches that
are joined in the final step to produce thiamin monophosphate
(Figure 8) (Jurgenson et al., 2009).
All genomes in our analysis contained the ThiCD functional
roles. The Thi4 role was only found in nine genomes, which were
all from the Bacteroidetes phylum. The second HET-P synthesis
route requires four functional roles: ThiS, ThiG, ThiF, and ThiO
or ThiH. The roles ThiO and ThiH convert glycine and tyrosine,
respectively, to glycine imine. The role ThiS carries a sulfur group
to ThiG, which combines the sulfur with glycine imine and DXP
to produceHET-P.Most predicted producers in our analysis used
the ThiH role except for four genomes that contained ThiO (two
from the Proteobacteria, one from the Actinobacteria, and one
from the Firmicutes phylum). Only two Actinobacteria out of
its 15 producers contained the ThiH or ThiO part of the path-
way; because their genomes contained all other functional roles,
they were predicted to be producers. In the final step, HET-P
and HMP-PP are combined to produce thiamin monophosphate
by ThiE. Although thiamin diphosphate is the functional ver-
sion of thiamin, the production of thiamin monophosphate was
considered sufficient for producer status. Only a single Bac-
teroidetes genome, Prevotella salivae DSM 15606, was missing
essential functional roles for thiamin biosynthesis. In the Fir-
micutes phylum, no Bacilli received a producer status, whereas
half of the Clostridia class genomes were predicted to synthe-
size thiamin. In Proteobacteria, all but oneGammaproteobacteria
genome were predicted to be producers. The remaining seven
producers from the phylum belonged to the Beta-, Delta-, and
Epsilonproteobacteria classes.
Taken together, these results show that the synthesis of thi-
amin monophosphate is present in the majority of all phyla,
except for Firmicutes, and this synthesis is most prevalent in
Bacteroidetes and Fusobacteria. Only a few genomes in the Bac-
teroidetes phylum contain the role Thi4, which can replace the
FIGURE 8 | Thiamin biosynthesis. The thiamin biosynthesis
subsystem contains 9 functional roles (Supplementary Table 2) and
10 metabolites. One functional role, sulfur carrier protein This, is
drawn as a metabolite because it is combined with other
metabolites and recycled in the pathway. Refer to Figure 1 for
figure explanations.
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longer HET-P biosynthesis route. The ThiH role in the longer
HET-P synthesis route is most commonly used by HGM organ-
isms; in contrast, the ThiO role is rarely present and is only
present in Actinobacteria and Proteobacteria genomes. In total,
56% of the HGM organisms have the ability to produce thiamin.
Comparison with Experimental Data
To assess the validity of our predictions, we compared our
results with existing experimental data in the literature. Here,
we considered only experimental studies that used defined media
added specific B-vitamins for growth, or that tested for B-vitamin
requirements or secretions specifically. We found experimental
evidence of B-vitamin requirements or secretions for 11 of our
HGM species. However, for four of these species, experimental
data were not found for the specific species that we analyzed.
In these cases, we compared the data to our analyzed strains
while keeping in mind that strains within a species can differ
substantially (Li et al., 2009). In total, we made eight predic-
tions for each of the 16 strains, resulting in 128 predictions. We
found that 113 of our predictions matched the experimental data
(88%, Table 4). This result suggests that predictions concern-
ing bacterial metabolism can be made based on well-annotated
genomes.
B-vitamin synthesis Patterns in HGM and other
Microbial Genomes
Examining the variation of the different synthesis pathways in
our former analysis, we wondered how the combinations of the
vitamins synthesized varied across the HGM genomes. Our data
consist of binary information regarding the distribution of path-
ways in 256 HGM and 257 non-HGM genomes, i.e., the pres-
ence or absence of a vitamin biosynthesis pathway in a genome
(Figure 9). We investigated the 28 = 256 possible patterns of the
eight studied pathways. Only 68 (27%) of the 256 possible path-
way patterns were found in the 256HGM genomes (Supplemen-
tary Table 1), suggesting that the occurrences of these B-vitamin
pathways may not be independent.
To determine whether the pattern occurrence and distribution
was HGM specific or a general feature of bacteria, we inspected
the B-vitamin metabolism distribution in 257 bacterial genomes
(non-HGM). We identified four groups: (1) 32 HGM-specific
patterns, (2) 36 patterns present in both HGM and non-HGM
sets, (3) 36 patterns found only in non-HGM genomes, and (4)
152 patterns found in neither. The 32 HGM-specific patterns
were present in 68 (27%) of the HGM genomes, and each pattern
was found in eight or fewer genomes. Three HGM-specific pat-
terns were found in eight genomes each: (i) the presence of only
niacin, pyridoxine, and thiamin pathways was found only in Acti-
nobacteria, (ii) the absence of all pathways except for niacin was
found in six Firmicutes and two Actinobacteria genomes, (iii) the
presence of all pathways except for biotin and folate biosynthesis
was found in five Firmicutes and three Proteobacteria genomes.
The remaining HGM-specific patterns were found in four or
fewer genomes each. The presence of these HGM-specific vita-
min biosynthesis patterns suggests that human gut microbes have
evolved to suit gut-specific conditions, resulting in complemen-
tary combinations of synthesized B-vitamins. Accordingly, we
observed ten pairs of inversed patterns, in which pathways that
TABLE 4 | Comparison of genomic predictions and experimental evidence.
Organism (SEED ID) B C F N P B6 R T References
Bacteroides fragilis NCTC 9343 (272569.17) • 2 • • • • • • Varel and Bryant, 1974
Bacteroides thetaiotaomicron VPI-5482 (226186.1) • • • • • • • • Varel and Bryant, 1974
Bacteroides vulgatus ATCC 8482 (435590.6) • 2 • • • • • • Varel and Bryant, 1974
Clostridium difficile CD196 (645462.3)a • • • • 2 • • • Karasawa et al., 1995
Clostridium difficile NAP07 (525258.3)a • • • • 2 • • • Karasawa et al., 1995
Clostridium difficile NAP08 (525259.3)a • • • • 2 • • • Karasawa et al., 1995
Escherichia coli str. K-12 substr. MG1655 (511145.6) • • • • • • • • Davis and Mingioli, 1950
Faecalibacterium prausnitzii A2-165 (411483.3) • 2 • • • • • • Heinken et al., 2014
Faecalibacterium cf. prausnitzii KLE1256 (748224.3)b • 2 • • • • 2 • Heinken et al., 2014
Faecalibacterium prausnitzii L2-6 (718252.3)b • 2 • • • • 2 • Heinken et al., 2014
Faecalibacterium prausnitzii SL3/3 (657322.3)b • 2 • • • • 2 • Heinken et al., 2014
Helicobacter pylori 26695 (85962.1) • • • • • • • • Testerman et al., 2001
Klebsiella pneumoniae 1162281 (1037908.3)c • • • • • • • • Anderl et al., 2000
Lactobacillus plantarum WCFS1 (220668.1) ◦ • ◦ • • • • ◦ Wegkamp et al., 2010
Listeria monocytogenes str. 1/2a F6854 (267409.1)d • • • • • • • • Tsai and Hodgson, 2003
Salmonella enterica subsp. enterica serovar Typhimurium str. TN061786 (946034.3) • • • • • • • • Skovran and Downs, 2000
B, biotin, C, cobalamin, F, folate, N, niacin, P, pantothenate, B6, pyridoxine, R, riboflavin, T, thiamin. Filled circles represent agreeing predictions and data, empty shapes represent
mismatches. •, predicted producers, •, predicted non-producers, 2, predicted producers, ◦, predicted non-producers. Footnotes list the comparative strain in the cases where the
predicted and experimental strains are different.
aC. difficile VPI 10463, KZ 1626, KZ 1630, KZ 1647, and KZ 1748.
bF. prausnitzii A2-165.
cK. pneumonia Kp1 and Kp102M.
dL. monocytogenes 10403, EGD-e, and L028.
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FIGURE 9 | NCBI based taxonomic trees and the presence or
absence of the eight B-vitamin biosynthesis pathways. The two
taxonomic trees show the (A) 256HGM genomes and (B) the 257
non-HGM genomes, along with heatmaps showing the presence
(green) or absence (black) of each vitamin pathway. The taxonomic
trees were produced using PhyloT: a tree generator
(http://phylot.biobyte.de/index.html), and visualized through iTOL
(http://itol.embl.de/) (Letunic and Bork, 2007, 2011).
were present or absent in one genome were absent or present in
another, respectively (Figure 10). Such pairs of organismsmay be
candidates for mutualistic or symbiotic interactions. For exam-
ple, several Bacteroidetes and Proteobacteria genomes contained
all biosynthesis pathways, except for cobalamin synthesis. In
the complementary pattern, found in eight Firmicutes genomes,
all biosynthesis pathways, except for cobalamin synthesis, were
absent. In comparison, only five pairs of inversed patterns were
observed in the analyzed non-HGM genomes.
We analyzed the distribution of pathway patterns of the HGM
genomes and noted similarities in the eight vitamin biosynthe-
sis capabilities at the phylum, class, order, and family levels.
Genomes in the phylum Actinobacteria demonstrated variations
in pathway distributions; however, the most conserved pattern,
the biosynthesis of niacin, pyridoxine, and thiamin, was present
in eight (35%) genomes, and all of these genomes were from
the order Bifidobacteriales and the family Bifidobacteriaceae
(Figure 9, Supplementary Table 1). Pathway distribution was
highly conserved in the phylum Bacteroidetes, which displayed
only six different patterns. The two most common patterns in
the Bacteroidetes phylum were the biosynthesis of all eight vita-
mins, which was present in 26 (51%) of the genomes in the
phylum, and the synthesis of all vitamins except for cobalamin,
which appeared in 17 (33%) of the Bacteroidetes genomes. Three
genomes could not produce cobalamin and pyridoxine, and three
did not meet the requirements for consideration as cobalamin
and folate producers. A single organism in the Bacteroidetes phy-
lum could produce all vitamins except for biotin and cobalamin.
One genome of the family Prevotellaceae, P. salivae DSM 15606,
was missing five biosynthesis pathways, and this organism only
produced pantothenate, pyridoxine, and riboflavin. The phylum
Firmicutes demonstrates the highest variability in pathway pat-
terns, containing 43 patterns in 130 genomes. However, this vari-
ability is not surprising in light of the taxonomic diversity within
the phylum itself. The most common pattern was the absence
of all biosynthesis pathways and was found in 30 genomes, 26
of which belong to the Lactobacillales order of the Bacilli class.
The Lactobacillales order also contained 9 out of 10 Firmicutes
genomes that contained only riboflavin biosynthesis. Genomes
of the Clostridia class showed an even larger diversity of path-
way patterns; these genomes contained 28 out of the 43 Firmi-
cutes patterns. The most common Clostridia pattern, the absence
of all synthesis pathways except cobalamin, was found in seven
organisms. All the analyzed Fusobacteria genomes belonged to
the family Fusobacteriaceae and displayed conserved patterns of
pathways. The most common pattern in nine of the 14 genomes
was the absence of only the pantothenate and pyridoxine synthe-
sis pathways. The pantothenate biosynthesis pathway was absent
in all of the genomes, whereas all genomes contained the biosyn-
thesis pathways for biotin, cobalamin, riboflavin, and thiamin.
The phylum Proteobacteria showed surprisingly conserved pat-
terns in light of the high divergence of the taxon. The class
Gammaproteobacteria contained 12 out of the 13 Proteobacteria
genomes that contained the biosynthesis of all vitamins except for
cobalamin. The only other genome to show this pattern was the
Betaproteobacteria Ralstonia sp. 5_7_47FAA. The remaining 14
patterns were only found in six or fewer genomes in the phylum,
and 10 patterns were observed in only a single organism each.
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FIGURE 10 | Inversed pattern pairs of HGM and non-HGM genomes.
The HGM genomes showed ten pairs of inversed patters, whereas the
non-HGM contained 5 pairs.
Finally, few pathway patterns were shared between the five phyla.
The presence of all pathways, except for cobalamin, was observed
in Bacteroidetes, Firmicutes, and Proteobacteria in 17, 1, and 13
genomes, respectively. Only nine out of the 68 patterns observed
in the HGM genomes were shared between two phyla, whereas
58 patterns appeared in a single phylum each.
Taken together, the distribution of pathway patterns was rel-
atively conserved, with only 68 patterns appearing in the 256
HGM genomes. A third of these patterns (20 out of 68) were the
inverse of another pattern, suggesting the existence of symbiotic
relationships for B-vitamin metabolism in the gut microbiota.
Amount of HGM B-vitamins Available to the Gut
Considering that the B-vitamin biosynthesis pathways seem to
be prevalent in the human gut microbiota genomes, we won-
dered whether gut bacteria have the collective capacity to produce
sufficient B-vitamins for daily human requirements. The assump-
tions underlying the calculation are described in the Method Sec-
tion. Overall, only four of the eight B-vitamins are predicted to
be produced in amounts that could cover at least a quarter of
the suggested dietary intake (Table 5). It must be noted that the
calculated values are speculative and do not represent the true
amount of B-vitamins provided by the human gut microbiota.
Discussion
In this study, we predicted the B-vitamin biosynthesis of 256
known human gut microorganisms based on their genome anno-
tations alone. Our key results are the following: (i) the majority
of our genome-based predictions match published experimental
TABLE 5 | Estimated maximal percentage of daily reference intake of the
eight vitamins that could be provided by the human gut microbiota.
Vitamin Intracellular DRIa [mg/day] HGMratio %DRI from
concentration HGM
[mmol/gDW]
Biotin 9.0 * 10−7 0.03 0.40 4.5
Cobalamin 8.5 * 10−8 0.0024 0.42 31
Folateb 5.0 * 10−5 0.4 0.43 37
Niacinb 3.3 * 10−3 15 0.63 27
Pantothenate 2.3 * 10−6 5 0.51 0.078
Pyridoxineb 5.8 * 10−4 1.3 0.50 86
Riboflavin 9.0 * 10−6 1.2 0.65 2.8
Thiaminb 8.7 * 10−6 1.15 0.56 2.3
aDietary reference intakes (Standing Committee on the Scientific Evaluation of Dietary
Reference Intakes and Its Panel on Folate, Other B Vitamins, And Choline, 1998). Values
averaged for male and female references intakes (ages 19–50).
bAtomic mass for dihydrofolic acid, nicotinic acid, pyridoxine 5’-phosphate, and thiamine
monophoshate.
data; (ii) B-vitamin biosynthesis is common in theHGM; and (iii)
inversed patterns of vitamin synthesis suggest symbiotic relation-
ships among HGM organisms with regard to B-vitamins. Taken
together, our data support the idea that the human gut micro-
biota has co-evolved relationships that are specific to the gut
environment.
The predictions of B-vitamin synthesis capability agreed well
with experimental data suggesting that the genomic analyses of
well-defined pathways can provide much information regarding
strain-specific metabolism. The prediction had a 12% error rate,
which represents a lower bound for the other HGM capabilities
(Table 4) as we compared against well-studied organisms with a
higher genome completeness than expected for genomes assem-
bled from metagenomic studies. One example of a wrong predic-
tion is L. plantarum WCFS1, in which all necessary functional
roles of the biotin pathway were missing. Because biotin is not
required for its growth (Wegkamp et al., 2010), either the organ-
ism does not need biotin or the manual curation of the path-
way requires additional data. The L. plantarum WCFS1 genome
contains the biotin-dependent protein biotin-protein ligase (Sup-
plementary Table 3), which suggests a need for biotin. All ana-
lyzed C. difficile genomes were predicted to produce pantothen-
ate as they contained all essential roles except ASPDC. However,
pantothenate is required in the growth medium of the compar-
ison strain (Karasawa et al., 1995). The strain difference may
explain the discrepancy but it is also possible that our essential
role constraints are too loose and that the absence of ASPDC
should lead to a negative prediction, even when it is the only
missing functional role in the pathway. The four F. prausnitzii
genomes were missing all essential roles for folate production
and were therefore predicted to require folate in their growth
media. In contrast, no significant folic acid consumption of F.
prausnitzii A2-165 has been reported (Heinken et al., 2014) and
additionally, it can grow in folic acid free medium (personal com-
munication, Dr. Delphine Saulnier). However, the genome of
F. prausnitzii A2-165 contains an annotated folate transporter
(Heinken et al., 2014) and the folate-dependent methionyl-tRNA
formyltransferase (UniProt ID: C7H5H7). We propose that F.
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prausnitzii A2-165 does not require folates for growth, although
the presence of folate in the growth medium might enhance the
growth rate. L. plantarumWCFS1 is missing all PABA functional
roles while it has been shown to synthesize folate in the absence
of folate precursors and PABA in the growth medium (Wegkamp
et al., 2010). This contradiction suggests an unknown route for
PABA biosynthesis, which is likely considering that two missing
archaeal enzyme families in the folate biosynthesis pathway had
recently been discovered (De Crecy-Lagard et al., 2012).
The two most commonly synthesized vitamins of the human
gut microbiota genomes were riboflavin and niacin, with 166
and 162 predicted producers, respectively. The gut-microbial
production of riboflavin has been associated with the immune
response through the activation of T-cells (Kjer-Nielsen et al.,
2012). Riboflavin has also been shown to be involved in the extra-
cellular electron transport chain in F. prausnitzii (Khan et al.,
2012). The conservation of the riboflavin biosynthesis pathway
can be explained by the exclusive importance of its derivatives,
FAD and FMN, because approximately 1–3% of cellular pro-
teins are flavoproteins (De Colibus and Mattevi, 2006; Abbas and
Sibirny, 2011). Niacin, a precursor for NAD, is another essen-
tial cofactor. NAD and its reduced and phosphorylated deriva-
tives (NADH, NADP, and NADPH) have many functions in cells,
such as serving as hydride donors and acceptors in redox reac-
tions (Belenky et al., 2007; Houtkooper et al., 2010), partici-
pation in bacterial and DNA ligase reactions (Wilkinson et al.,
2001), and roles as molecules that signal the cellular redox status
(Houtkooper et al., 2010). However, the two synthesis pathways
are distributed differently over the five phyla. Riboflavin synthesis
is mainly found in Bacteroidetes, Proteobacteria, and Fusobacte-
ria, but it is only found in half of the Firmicutes genomes and very
few Actinobacteria (Figure 7). In contrast, the niacin biosynthe-
sis pathway is more evenly distributed over the genomes of the
five phyla (Figure 4). Such differences between the distributions
of these two pathways can have various explanations. First, this
variation may reflect their evolutionary history; riboflavin syn-
thesis appears to be more ancient than the NAD biosynthesis
pathway (Gazzaniga et al., 2009). Second, the biosynthesis of
riboflavin and its derivatives is a quite straightforward pathway
(Abbas and Sibirny, 2011), whereas the biosynthesis of NAD is
very complex and includes numerous versions of salvage path-
ways in various bacterial taxa (Kurnasov et al., 2003; Gerdes et al.,
2006; Galeazzi et al., 2011; Cialabrini et al., 2013).
The human gut microbiota is a large microbial community, in
which metabolites are shared among individual microorganisms
(Wolin, 1974; Chassard et al., 2005). The production of all vita-
mins and the absence of all biosynthesis pathways was one of the
most common patterns in the HGM (Figure 10). The absence of
all biosynthesis pathways was only found in the Firmicutes phy-
lum, whereas the presence of all eight pathways was foundmainly
in the Bacteroidetes and in several Proteobacteria (Figure 9, Sup-
plementary Table 2). This distribution of vitamin biosynthesis
patterns is interesting given that a higher ratio of Bacteroidetes
to Firmicutes has been linked to a healthier gut microbiota com-
pared with that in obese individuals (Turnbaugh et al., 2006).
Inversed pattern pairs in HGM was twice as frequent than in
non-HGM, and 70% more genomes were associated with these
pairs in the HGM compared to non-HGM (Figure 10). These
results suggest that the trait of sharing B-vitamins has evolved
in the gut microbes.
HGM can supply the host with biotin, folate, and riboflavin
(Hill, 1997; Rossi et al., 2011). Human colonocytes contain
transporters for several B-vitamins, such as RFT1 for riboflavin
(Yonezawa et al., 2008), FOLR1 for folate (Crott et al., 2008),
and the multivitamin transporters SMCT1 (Li et al., 2003) and
SMVT (Prasad et al., 1999). It has therefore been speculated
that the HGM contributes to B-vitamin homeostasis (Said, 2004)
because most of the dietary vitamin absorption occurs in the
small intestine. The large intestine contains the highest density
of microbes in the human gut; thus, it seems likely that bac-
teria provide human intestinal cells with sufficient B-vitamins
to avoid deficiencies during short periods of vitamin-poor diet.
According to our estimation, the gut microbiota would not be
able to provide the host with the daily recommended intake of
B-vitamins (Table 5) and a large portion of these vitamins may
be taken up by non-producing gut microbes, which compete with
the host. In fact, our results indicate that human gut microbes
actively synthesize B-vitamins and provide them to their neigh-
boring bacteria through symbiotic relationships. A high fraction
of the recommended pyridoxine intake and about a third of the
recommended intake of cobalamin and folate could be available
from the gut bacteria (Table 5). Consistently, these vitamins are
thought to be produced by the human gut microbiota in addi-
tion to dietary uptake (Herbert, 1963; Roth, 1981; Leblanc et al.,
2013). In fact, pyridoxine deficiency due to dietary deficiency is
rarely observed (Rucker et al., 2007). Cobalamin and folate defi-
ciencies are mainly reported in elderly people (Herbert, 1963;
Andres et al., 2004; Clarke et al., 2004), who have been shown to
have a less diverse and metabolically active microbiota (Wood-
mansey et al., 2004; Claesson et al., 2011). In addition, cobal-
amin and folate have several metabolites derived beyond their
basic forms, and the host may not absorb these compounds. For
example, it has been shown that little of the corrinoids found in
human feces are gut-bacteria derived (Allen and Stabler, 2008),
and it has been proposed that the most of the corrinoids pro-
duced by the gut bacteria are taken up by non-producers in the
gut (Degnan et al., 2014). Vitamin B12 has recently been sug-
gested as a modulator of gut microbial ecology (Degnan et al.,
2014). We propose that other B-vitamins could also have a gut
microbiota-modulating role. In this study, we have not analyzed
vitamin transporters because little is known about the B-vitamin
export from bacterial cells (Rodionova et al., 2014). However, if
B-vitamins are released into the gut during cell lysis, any vitamin
producer can be considered a vitamin source, regardless of its
transporter expression. Taken together, our results highlight the
fact that the microbiota does indeed contribute to the B-vitamin
pool of the gut and that the host can benefit to some extent from
the B-vitamin biosynthesis of the microbiota.
In conclusion, our genomic assessment of 256 HGM organ-
isms suggests that these organisms have co-evolved in the gut and
shows several possible symbiotic and competitive relations within
the gut microbiota. The co-evolution of B-vitamin biosynthesis
in gut microorganisms has likely benefitted the host’s vitamin
homeostasis.
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